Introduction
Cell surface receptors have been shown to play pivotal roles in both proliferation and dierentiation by way of external signals such as growth factors and peptide hormones. Many of these receptors have tyrosine kinase activity which is reponsible for eliciting the cellular response. Receptor tyrosine kinases typically have an extracellular ligand binding domain, a transmembrane domain and an intracellular domain responsible for the tyrosine kinase activity of the receptor and subsequent signal transduction. Speci®c classes of tyrosine kinases can be distinguished by the structure of their extracellular domain and by the placement of key tyrosine residues believed to be important for kinase activity. The c-met family of receptors is such a class of receptors (Dean et al., 1985; Bottaro et al., 1991; Naldini et al., 1991) . Members of this family include c-met (the receptor for hepatocyte growth factor; HGF), Ron/Stk (the receptor for hepatocyte growth factor-like protein/macrophage stimulating protein; HGFL; Ronsin et al., 1993; Gaudino et al., 1994; Wang et al., 1994 Wang et al., , 1995 and sea (for which a ligand has not yet been identi®ed; Hu et al., 1993) .
The ligands for this class of receptors are growth factors that are structurally similar but elicit responses in dierent cell types and tissues, consistent with the dierent expression patterns of the receptors. The cDNAs coding for HGFL and macrophage stimulating protein (MSP) have been found to code for the same protein Bezerra et al., 1993; Shimamoto et al., 1993; Yoshimura et al., 1993) . HGFL and HGF have the same domain composition with four kringle domains followed by a serine proteaselike domain and are approximately 40% identical at the amino acid level (Yoshimura et al., 1993; Nakamura et al., 1989; Degen et al., 1991; Han and Degen, 1993) . HGFL induces a change in shape of mouse peritoneal macrophage, stimulates resident peritoneal macrophage to undergo a chemotactic response to endotoxinactivated mouse serum, causes marked macrophage spreading and morphological changes in vitro, stimulates ingestion of sheep erythrocytes opsonized with IgM anti-Forssman antibody and mouse C3b, and inhibits cytokine-or endotoxin-induced expression of the inducible nitric oxide synthase Skeel, 1976, 1978; Skeel and Leonard, 1994; Skeel et al., 1991; Wang et al., 1994) .
The human HGFL receptor, Ron, is a heterodimeric glycoprotein with disul®de-linked chains of 150 kD and 35 kD (Ronsin et al., 1993; Gaudino et al., 1994) . The protein is synthesized as a single chain protein of 185 kD that is cleaved to its heterodimeric form before exposure to the cell surface. The protein contains 1400 amino acids which includes a 24 amino acid signal peptide, a putative extracellular domain of 933 amino acids, a 25 amino acid transmembrane domain and an intracellular tyrosine kinase domain of 418 amino acids. The tyrosine kinase domain of Ron is 63% identical to the same domain in the HGF receptor, while the extracellular domain is only 25% identical. Similar placement of cysteines in the extracellular domains of the Met and Ron receptors indicates that these domains are related. The mouse cDNA coding for Ron (originally called Stk for stem cell-derived tyrosine kinase; Iwama et al., 1994 ) is 73.6% identical to the human Ron cDNA.
In the mouse, the Ron receptor has been found to be expressed at various stages of hematopoietic cell dierentiation: in stem cells, in peritoneal macrophage and in bone-derived osteoclasts (Iwama 1994 Kurihara et al., 1996) . The developmental expression of Ron was studied by in situ hybridization analysis and was found to be expressed relatively late in development (day 12.5) in speci®c areas of the central and peripheral nervous system, in speci®c cell types of the developing bone and in the glandular epithelia along the digestive tract (Quantin et al., 1995) .
In a number of human cancers, tyrosine kinase receptors have been shown to be constitutively activated by genetic rearrangements resulting in novel chimeric proteins containing tyrosine kinase domains with altered amino-terminal regions Sawyers and Denny, 1994) . Speci®cally, the tyrosine kinase domain of the Met receptor has been shown to be converted to a hybrid oncogene by recombination with a gene designated TPR (Cooper et al., 1984) . Further, a splice variant of the Ron transcript obtained from a human gastric cancer cell line has been shown to induce constitutive tyrosine kinase activity and is associated with an invasive phenotype . This variant was hypothesized to be alternatively spliced such that a single exon was deleted. However, further analysis of this variant awaits information regarding the genomic structure of the Met receptor family. In this paper we report the ®rst complete gene structure of one member of this tyrosine kinase family, namely, Ron. Further, although the sites of synthesis of the Ron receptor have been identi®ed, little is known about how expression of this receptor is regulated. Herewithin, we have made initial attempts to study the regulation of this gene product in newly identi®ed Ron expressing cell lines. Transcription start sites for the Ron gene transcript have also been mapped. It is noteworthy that primer extension experiments performed on a variety of Ron expressing cell lines and on mouse colon tissue gave identical transcription initiation patterns suggesting a common regulatory mechanism may be utilized to express Ron in a variety of cell types. Transient transfection analyses with sequential deletions of the 5'¯anking region of the Ron promoter fused to a reporter construct illustrated the presence of negative and positive regulatory elements in a variety of cell types which express this gene. Speci®c trans-acting factors were shown to bind to a subset of sequences encompassing both the positive and negative elements.
Results

Characterization of the mouse Ron gene
The mouse gene coding for the Ron receptor was isolated from a genomic DNA library obtained from mouse strain 129/SvJ. Sequence was determined for 16 399 bp of continuous DNA using overlapping subclones (Figures 1 and 2 ). The size of the gene from the codon for the initiator methionine to the polyadenylation site is 13 244 bp. Sequence was determined upstream of the initiator methionine (2772 bp) and downstream of the polyadenylation site (383 bp).
The coding sequence is represented by 19 exons that range in size from 81 ± 1236 bp in length (Table 1) . The ®rst exon is the largest (1236 bp; Figure 2 ), while the 3' most exon containing 3' nontranslated sequence is 570 bp in length. The 18 intervening sequences range in size from 80 to 3142 bp in length. Excluding the largest three intervening sequences, the average size is 200 bp. Exon sequences represent 33.4% of the gene sequence. All splice junction sequences conform to the consensus sequences for ends of intervening sequences where GT and AG are found at the 5' and 3' ends, respectively (Table 2 ; Mount, 1982) . Six polymorphic sites were identi®ed by comparison of the sequence of exons in the gene to the mouse Ron cDNA (Table 3; Iwama et al., 1994) . Four of these are in exon 7 and one each in exons 18 and 19. Five of the dierences are in coding regions and result in three amino acid substitutions consisting of Val to Ile, Gly to Ala and Val to Ala at residues 713, 714 and 719, respectively.
Southern hybridization analyses performed extend the restriction map of the Ron gene ( Figure 1 ) and, given the singularity and intensity of the bands obtained, demonstrate that this gene is present as a single copy in the mouse genome (data not shown). The genes for the Ron receptor and its ligand, HGFL, have been previously mapped to the same chromosomal locus in both the mouse and human genomes Figure 1 Partial restriction map of the mouse Ron gene and¯anking regions. Placement of restriction sites are shown above the structure of the gene. The region contained within the shaded portions of the map was characterized completely by DNA sequence analysis. Exons are indicated by blackened boxes while intervening sequences are those regions between exons. Sequence upstream (2772 bp) and downstream (383 bp) of the gene was also determined. Restriction sites outside of the shaded region were determined by Southern analysis of genomic DNA. Whether other sites are present in this region has not been determined. The orientation of transcription is indicated by the placement of the 5' and 3' at the ends of the map. Two copies of B2 repetitive DNA and one copy of B1 repetitive DNA sequences are shown as solid boxes below the map. Regions subcloned into Bluescript for further characterization are indicated. The scale is shown in kilobases (kb) (Ronsin et al., 1993; Han et al., 1991; Iwama et al., 1994; Degen et al., 1992) . Unfortunatley, not enough information from these experiments has been obtained to determine whether or not these two genes are genetically linked.
Identi®cation of Ron expressing cell lines
RT ± PCR analysis was used to identify cell lines and adult mouse tissues that express the Ron gene product. Table 4 shows a summary of the mouse tissues and cell Figure 2 The sequence of the 5'¯anking region and exon 1 of the mouse Ron receptor gene. Nucleotide numbering is shown on the right and corresponds to the last nucleotide of each line. DNA sequence upstream of the initiator methionine is numbered in a negative fashion; the adenine nucleotide of the ATG initiator codon is designated as nucleotide 1. Asterisks note the multiple transcription start sites at nucleotides 7951, 7936, 7911, 7895, 7288, 7262 and 7206. A B2 repetitive element is underlined in the 5'¯anking region. Exon 1 is shown with the translated amino acid sequence above the sequence of the gene. The 5' end of the ®rst intervening sequence follows exon 1 and is indicated by lower case letters lines that were analysed for Ron expression. As a control for RNA integrity, each RNA sample was analysed by gel electrophoresis prior to RT ± PCR analysis. Furthermore, to control for possible contamination all RT ± PCR reactions were performed with and without reverse transcriptase. Additionally, all samples were subjected to RT ± PCR using a variety of PCR primers speci®c for the mouse Ron transcript with Ron expression veri®ed by PCR products of speci®c sizes. To verify the presence of Ron expression in intestinal tissues for further analyses, in situ hybridization analyses were performed. Figure 3 shows an in situ hybridization experiment performed on adult mouse colon tissues. These analyses con®rm that Ron is expressed in the mouse colon and that expression of Ron may be localized to epithelial cells of the intestine.
Primer extension analyses
In order to determine the endogenous transcriptional start point (tsp) of the mouse Ron transcript, primer extension analysis was performed. RNA was isolated from a variety of Ron expressing cell lines and primer extensions were performed with a selection of primers complementary to various coding regions of the Ron gene. Transfer RNA was used as a negative control for all of the primers used. Figure 4 shows the results of several primer extension experiments. A map of primers used to determine the tsp is shown in Figure  4a . Primer extension products of 206, 180 and 124 bp were obtained on RNA isolated from MEL cells (Figure 4b , lane 1) and mouse colon tissue ( Figure  4b , lane 2) with primer k which is located 82 bp upstream of the translation start point. These results place the major transcription start sites at 288, 262 and 206 bp upstream of the Ron initiator methionine. Other less prominent tsp were also identi®ed throughout the Ron promoter region. Based on the observation that long 5' untranslated regions of Ron mRNA have been isolated and on the fact that no consensus TATA box was found in the Ron 5'¯anking DNA, primer extension experiments were performed along a large portion of the Ron 5'¯anking DNA to map other potential tsp. No extension products were found using primers o (Figure 4c (Iwama et al., 1994). b Where type O splice sites occur between codons, type I between the ®rst and second base of a codon and type II between the second and third base of a codon (Sharp, 1981) GTC  TTC  GCC  GAG  GGT  TGG  TGT  TAT  GTC  GTG  GCC  GCA  AAC  GCT  TGG 
Deletion analyses of the 5'¯anking DNA of the mouse Ron gene
To elucidate the DNA sequences involved in the celltype speci®c expression of the mouse Ron gene, a series of Ron/CAT promoter plasmids were constructed. Figure 5a depicts the dierent regions of the Ron promoter cloned into the promoterless CAT vector, pBLCAT6. All of the Ron/CAT promoter constructs have as their 3' terminus the A nucleotide of the ATG start codon (designated as +1, Figure 2 ). Equimolar amounts of each chimeric clone were examined by transient transfection into CMT-93, EL-4 and S49 cells. CMT-93 cells express the Ron transcript whereas S49 and EL-4 cells do not (see Table 4 ). In cell lines which were determined not to express Ron, transfections were performed with only three Ron/CAT promoter constructs, namely, pRonCAT(71843/+1), (7465/+1) and (736/+1). Shown in Figure 5b is a histogram of the average transfection data for the Ron/ CAT reporter constructs transfected into CMT-93, S49 and EL-4 cells. For each transfection, the activity of the Ron/CAT promoter constructs was normalized to pRonCAT(71015/+1) from CMT-93 cells. The activity of the parental plasmid, pBLCAT6, was then normalized to 1 in all cell lines. As a positive control, pD5CAT, which contains the SV40 promoter/enhancer region upstream of the CAT gene was used (Berkner and Sharp, 1985 , data not shown). The most active Ron/CAT promoter construct in CMT-93 cells had approximately 10% of the amount of CAT protein produced compared to the positive control. None of the Ron/CAT promoter constructs tested were active after transfection into EL-4 or S49 cells ( Figure 5b ). This lack of activity in EL-4 and S49 cells was not due to inecient transfections as pD5CAT levels in these cells were comparable to those obtained from CMT-93 cells. Additionally, pRonCAT(+1/72772) in which the Ron sequence was inserted in the opposite orientation with respect to the CAT gene had little activity in CMT-93 cells.
In CMT-93 cells, only two constructs had activity that was signi®cantly over background levels ( Figure  5b ). The construct pRonCAT (72772/+1) had CAT protein levels which were slightly over twice that of background and pRonCAT(7465/+1) was approximately 4.5-fold higher. When 180 bp of Ron¯anking sequence was excised from pRonCAT (7465/+1) to create pRonCAT(7285/+1), the activity of the latter Ron/CAT reporter construct decreased by 2.5-fold. These results suggest that the region between 7465 to 7285 may contain a positive regulatory element. Additionally, a negative regulatory element may be contained between nucleotides 7585 to 7465. When this region is present, the amount of CAT protein produced falls to approximately background levels.
Localization of transcription start points in transfected Ron/CAT promoter plasmids
In order to determine if the Ron/CAT reporter gene constructs utilized the endogenous tsps, reverse transcriptase (RT) ± PCR was performed on RNA isolated from cell lines which had been transiently transfected with various Ron/CAT promoter constructs. A primer (z, Table 5 and Figure 4 ) complementary to the CAT gene was used to generate cDNA products from RNA of transfected cells. These products were then ampli®ed in a PCR reaction with a number of primers in the Ron 5'¯anking DNA. Figure  6a shows RT ± PCR products from RNA isolated from CMT-93 cells transfected with pRonCAT (71843/+1) (lanes 1 and 2), pRonCAT(7465/+1) (lane 3) or with pRonCAT(736/+1) (lane 4). PCR was performed using primers q and z (lane 1) or primers a and z (lanes 2 ± 4). A PCR product of 979 bp was obtained in the pRonCat(71843/+1) transfected RNA. Primer a is located upstream of the identi®ed endogenous tsps in all of the transfected constructs and serves as a undertaken with each subregion. As shown in Figure  7a , a speci®c protein complex(es) was shown to bind to the 7585/7508 region. This complex was speci®cally competed with an identical unlabeled sequence ( Figure  7a, lanes 3 and 4) . DNA of unrelated sequence, however, was unable to compete for protein binding (Boshart et al., 1992) . pBLCAT5 contains the herpes simplex virus (hsv) thymidine kinase (tk) promoter 5' to the CAT gene. As depicted in Figure 8 , the 7585/ 7508 region was able to consistently decrease the activity of pBLCAT5 by approximately one third after transfection into CMT-93 cells. The 7375/7285 region appeared to have no eect on transcription in this context.
Discussion
The entire nucleotide sequence of the mouse Ron gene was determined and it was found that the extracellular domain of the Ron receptor is encoded by exons 1 ± 12, with the signal peptide and putative activation domain localized to the ®rst exon. The transmembrane domain is encoded by exon 12 and the intracellular tyrosine kinase domain is localized to exons 13 ± 19. Conserved tyrosines that might be involved in phosphorylation events are localized to exons 17 ± 19. The sequence and structure of the Met receptor indicate that several of these tyrosines, when phosphorylated form a bidentate docking site for proteins that bind SH-2 domains (Ponzetto et al., 1994; Zhen et al., 1994) . Tyrosines at TGACTAGTCTAGAGCCCAGAGAAACCCTGTTTCTATGTAACAA  TGACTAGTCTAGAGCCATCCTGGAAAGAGGACTCTGGATTCCA  TGACTAGTCTAGAGCCGCATTACTCTGTCCAGTGCATTCCTGGT  TGACTAGTCTAGAGCCCACCTCCCTTCGACTTTGATCCAAGTAG  TGACTAGTCTAGAGGGGTCCACAGCCAGGTGCTCAGACCACAAG  TGACTAGTCTAGAGTGCCTAAAGCTGGTCTCAGCTCGGACCCTG  ACTAACGCTCGAGTGAGCTGGGGCCCCTTGGGAATCCCAGAAG  TGACTAGTCTAGACCTGGACCTTCTGGGATTCCCAAGGGGCC  GGACAATCTGGCTCCTCTCTCCTCAT  CCTTTCTCTCTGGCTTGTGGTCTGAGCACC  CTCGGATCCTGTCACTGTGGCCTCA  ACACGGCAATGGCACGATCA  AGACTGCCCTCAAACTCAGAGATCC  AGAGGTATTCTTAGCCAGGCAGCTG  AGGTGCTCAGACCACAAGCCAGAGAG  TGTACCAGGGCACCGGAGGAGAGGCA  GATCCGGTACCAAGCTTTGAGCTGGGGCCCCTTGGAATCCCA  ACCGGTGTGACCGGCAGAAGGAGTG  CCCTATCTGCAGATGAAGGGGGACC  TGATCCAAGCTTTGGAAAGAGTCAGACAGAGCTGGAAAGAAA  TGACTATCTAGAGCCCCAGTGGGTGCGGCAGGGCTGGGGGCG  TGATCCAAGCTTCCGCATTACTCTGTCCAGTGCATTCCTGGT  TGACTATCTAGAAGGAACACTGTCAGGCACTAGTTCACCATG  AGGAACACTGTCAGGCACTAGTTCACCATG  TGACTAGTCTAGATGGAAAGAGTCAGACAGAGCTGGAAAGAAA  GCCCCAGTGGGTGCGGCAGGGCTGGGGGCG  TGACTAGTCTAGAGTGCCTGACAGTGTTCCTATGAAAGAGGGC  CAGGACAATCTGGCTCCTCTCTCCTCATGG  GCAGCGTTCTAACCTCAACCAGATGGGTTG residues 1330 and 1337 in exon 19 of the mouse Ron receptor are in analogous positions as those in Met that are involved in the docking site. Further, the constitutively active splice variant of Ron found in the gastric carcinoma cell line KATO-III may be explained by an alternative splicing event involving the deletion of exon 11 .
The full-length mouse Ron cDNA starts at nucleotide 7256 in the gene (Figure 2) . The truncated Ron cDNA identi®ed by Iwama and coworkers (Iwama et al., 1994) has its 5' end in intervening sequence J, 53 nucleotides upstream of exon 11, and includes exons 11 ± 19 (Figure 1) . It remains to be determined whether the transcription start site for this truncated mRNA is present in intervening sequence J or whether one of the sites that we identi®ed in the upstream region of the gene is used. It also has not been determined whether the truncated form of the protein, which would include very little of the extracellular domain, is functional.
A search of GenBank identi®ed regions of repetitive DNA sequence which includes two copies of B2 and one copy of B1 type repetitive sequences. These types of repeats are analogous to Alu repetitive sequences found in the human genome (Krayev et al., 1982) . The B2 repeats in the mouse Ron gene are in the 5'¯anking region (nucleotides 71782 to 71604, Figure 1) and in intervening sequence G, while the B1 repeat is present in intervening sequence R. A short region of homology with U6 RNA was found in the 5'¯anking region at nucleotides 71878 to 71809 (Figure 1 ). Besides homology with the cDNAs for the Met and sea receptors and with other receptor tyrosine kinases in exons 16 to 18, no other signi®cant regions of homology with sequences within GenBank were identi®ed.
Little is known about the expression of Ron in various tissues and cell lines. Initial eorts were focused on cell lines of the gastrointestinal tract including mouse colon tissues. In situ hybridization analyses on mouse colon tissues indicated that Ron is expressed in the mouse colon and that expression of Ron is primarily localized to the epithelial cells of the intestine (Figure 3) . The function of Ron in the intestinal tract is unknown, although Ron may be involved in the proliferative capacity of the intestinal epithelia, a cell layer that is being constantly turned over. Activation of Ron has been shown to stimulate DNA synthesis in various epithelia, osteoclast-like, and neuroendocrine cell lines (Gaudino et al., 1994) , consistent with a potential role in the proliferation of the gut epithelium. An immortalized mouse colon-derived cell line, YAMC, also expresses Ron mRNA (Figure 4 ). Primer extension analysis con®rms the presence of Ron mRNA in adult mouse colon, NIH3T3 and YAMC cells (Figure 4) . The presence of Ron in NIH3T3 cells excludes the possibility that Ron expression is limited to cells of epithelial origin and may imply that a variety of cell types are responsive to HGFL.
In order to determine the transcriptional start point (tsp) of the Ron gene, primer extension analyses were performed. Based upon the fact that multiple sizes of the Ron mRNA transcript have been detected and since long 5' untranslated regions in the Ron cDNA have been reported (Gaudino et al., 1994; Iwama et al., 1994; Del Gatto et al., 1995) , we performed primer extension reactions utilizing multiple primers located throughout the 5'¯anking region of the Ron gene. Primer extension experiments localized major tsps at nucleotides 7911, 7895, 7288, 7262 and 7206; minor tsp sites were located at 7951 and 7936 (Figure 2 ). Other less prominent tsps were also identi®ed throughout the Ron promoter. No additional start sites were found 5' to the 7951 site. Ribonuclease protection analyses were performed to con®rm the primer extension data. These assays were unsuccessful, most likely due to minor initiation events that can occur along the Ron gene and by the minute quantities of Ron mRNA produced. Overall, the primer extension analyses suggest that initiation can occur at multiple locations along the Ron gene synonymous with a putative complex regulatory Gatto et al., 1995) . One transcription start site in the mouse Ron gene has been localized to a comparable site (nucleotide 7206; Figure 4 ). Although it is probable that the Ron and Met genes have a similar exon/intron organization due to the apparent gene duplication events resulting in the Met family of receptors, this can not yet be determined since the structure of the gene for Met has not been characterized. The 5' end of the human gene coding for Met has been isolated and characterized (Gambarotta et al., 1994) . It was determined that the ®rst exon coded for only the 5' nontranslated sequence approximately 24 kb upstream of the second exon which encodes the initiator methionine. The intervening sequence occurs 14 bp upstream of the initiator methionine (Gambarotta et al., 1994) . The 5' noncoding region is 408 bp in length. Our results show that there are transcription start sites in the region upstream of the putative ®rst exon of the mouse Ron gene. It is also unlikely that an intervening sequence is present in a comparable position in the mouse Ron gene 14 bp upstream of the initiator methionine since the mouse Ron cDNA includes 256 bp of 5' nontranslated sequence that is immediately upstream of the initiator methionine in the gene (Gambarotta et al., 1994) . Whether alternative transcripts initiate upstream of the characterized 5'¯anking region of the mouse Ron gene remains to be determined.
Examination of the 5'¯anking region of the mouse Ron gene unveils a number of potential regulatory elements (Table 6 ). Two putative Sp1 binding sites are located at nucleotides 7297 and 7728. Both alphaand gamma-interferon response elements are present, as well as potential binding sites for Ets-1, estrogen and NFk-kB. As has been reported for the human Ron promoter and for other tyrosine kinase receptor promoters, the mouse Ron promoter does not contain a TATA or CCAAT box. The precise role of the multiple potential regulatory elements in the¯anking DNA of the Ron gene has yet to be determined. However, the presence of these numerous elements suggests that the expression of this gene may be regulated by a variety of cytokines and steroid hormones. This observation is further reinforced by the ®nding that mice lacking the Ron/Stk receptor appear to harbor an increased level of nitric oxide, mediated by gamma-interferon, and are also more susceptible to endotoxic shock (Correll et al., 1997) .
Transient transfection analyses with sequential deletions of the mouse Ron¯anking DNA fused 5' to the CAT gene were performed to identify potential regulatory sequences governing the expression of this gene. These analyses implicated several regions which may be critical for the expression of Ron in CMT-93 cells. One region, containing nucleotides from 7465 to +1, contained the minimal promoter to drive Ron expression in CMT-93 cells. Deletion of the 7465 to 7285 region diminished CAT expression to approximately background levels in both cell types. These results suggest that a positive regulatory element is contained within this 180 bp region. Furthermore a cell-type speci®c negative regulatory element may be located between nucleotides 7585 to 7465 since inclusion of this sequence results in a decreased level of CAT protein compared to pRonCAT(7465/+1) (refer to Figure 5 ). No Ron/CAT promoter activity was discovered in transfected S49 or EL-4 cells in which endogenous Ron expression was also not detected (Table 4) . 7297, 7728 7302, 7444, 7726, 7926 7302, 7407, 7637, 71019 7146, 7165, 7487, 7493, 7549 7274, 7336, 7351, 7371, 7505, 7541 71013, 71021 742, 762, 7235, 7313, 7457, 7935, 7962 Gel mobility shift analyses with the negative 7585/ 7508 region and the positive 7375/7285 region suggest that potential trans-acting factors involved in the regulation of the Ron message may reside herewithin (Figure 7) . Analysis of the positive region identi®ed four copies of the Ets-1 binding sequence. Interestingly, Ets-1 has been shown to up-regulate the expression of Met, the receptor for HGF (Gambarotta et al., 1996) . However, polyclonal antibodies directed against members of the Ets family failed to produce supershifted complexes in gel mobility shift analyses with the 7375/7285 region (data not shown). These data, however, do not preclude the possibility that Ets protein may also have a regulatory eect on Ron expression. In addition to Ets-1, potential binding sites for Sp1, Ap1 and Ap2 (Figure 7c and data not shown) are located within the positive 7375/7285 region. In competition analyses with these putative binding sequences, only the consensus site for the transcription factor Sp1 appeared to compete with the labeled 7375/7285 region (Figure 7c ). The gel mobility shift data therefore suggest that Sp1 or a protein with a binding speci®city similar to Sp1 may be involved in the positive regulation of the mouse Ron gene. Ets-1 putative binding sites are also located in the negative 7585/7508 region. However, Ets-1 does not appear to be involved in the negative regulation of Ron ( Figure  7a ) through this element. As yet, sequence information has not provided clues as to possibilities for the identi®cation of the CMT-93 speci®c factor(s) which binds to the 7585/7508 regulatory sequences. Continued studies are aimed at determining the identity of the trans-acting factor(s) with Ron sequence speci®city.
Transactivation studies with the 7585/7508 region show a consistent signi®cant decrease in transcriptional activity compared to a heterologous promoter control (Figure 8) , providing evidence for a bona®de negative regulator. However, no change in promoter activity was identi®ed in transactivation studies with the 7375/ 7285 region. This latter observation may suggest that sequence context or spacing constraints may play an important role for regulation from this region. Alternatively, it is plausible that loss of promoter activity in the 7465/7285 region may coincide with loss of potential transcription start sites and not with the loss of a bona®de positive element.
The promoter activity of the human Ron gene has been tested by transfection of Ron/CAT promoter constructs into HeLa and SVK14 (SV40 transformed keratinocytes) cell lines (Del Gatto et al., 1995) . Constructs containing 1206 bp of 5'¯anking sequence were active in both cell lines. Sequential 5' deletions resulted in successive decreases in CAT activity. Approximately 300 bp of sequence immediately upstream from the initiator methionine had little or no CAT activity while a construct containing an additional 600 bp of 5'¯anking sequence resulted in approximatley 30% of the activity of the construct with 1200 bp of 5'¯anking sequence. Although no data regarding trans-acting factors were presented, these preliminary results suggest that multiple regulatory elements may be contained within 300 ± 1200 basepairs upstream of the translation start site of the human Ron gene. Even though the mouse and human promoters share no overall sequence identity, some common themes emerge. Analogous to the human Ron gene promoter, no TATA or CCAAT consensus motifs were found in the mouse Ron 5'¯anking DNA (Del Gatto et al., 1995) . Furthermore, in both promoters, multiple Sp1 consensus binding sites were found. Deletion of successive regions which encompass potential Sp1 binding sites in the human promoter result in approximately twofold reductions in CAT activity. Likewise, deletion of the region between nucleotides 7465 to 7285 in the mouse Ron promoter results in a similar reduction in the amount of CAT protein produced ( Figure 5 ). This region in the mouse promoter also contains a Sp1 binding site. Further, an Sp1 concensus sequence is able to compete for protein binding to a subset of this region.
In summation, this paper represents the ®rst genomic characterization of a Met receptor family member. Members of this pivotal tyrosine kinase family are thought to confer pleiotropic cellular responses involved in cell growth and extracellular matrix invasion possibly leading to oncogenic and metastatic cellular phenotypes following alteration. The information presented in this report underlie a potential commonality regarding regulation of the Ron gene product and identify both positive and negative regulatory regions in the Ron promoter. Investigations encompassing alterations in genetic rearrangements and altered regulatory mechanisms may now be further advanced.
Materials and methods
Probes
A partial mouse cDNA coding for Ron was obtained from Amgen. This cDNA, cloned into pSPORT1 (BRL), is 4.4 kb in length and is missing a small amount of sequence coding for the signal peptide at its 5' end. The cDNA spans nucleotides 308 ± 4669 of the Stk cDNA (Iwama et al., 1994) . A 1900 bp fragment coding for the 5' end of the cDNA was isolated after digestion of the cDNA with SalI and EcoRI.
Isolation of the mouse Ron gene
A lDASHII genomic DNA library, prepared with DNA isolated from 129/SvJ mice (Shull et al., 1992) was screened by in situ plaque hybridization using the 1.9 kb SalI/EcoRI fragment coding for the 5' end of the mouse Ron cDNA. High stringency conditions were used for hybridization and washing of the ®lters (Degen and Davie, 1987) . Nine positive plaques were identi®ed on the ®rst screen; six remained positive on subsequent screenings. DNA from one clone was digested with either SstI, EcoRI or BglII and fragments encoding the gene were subcloned into Bluescript (Stratagene). Overlapping subclones spanned approximately 16.5 kb of DNA.
DNA sequencing
Double stranded DNA was sequenced by the dideoxy chain termination method using speci®c oligonucleotide primers based on the sequence of the mouse Ron cDNA or mouse Ron gene sequence (Sequenase kit; United States Biochemicals). Initially, sequencing primers were synthesized every 300 bp apart based on the sequence of the mouse Ron cDNA such that oligonucleotides alternated strands every 150 bp. Subsequently, oligonucleotides were synthesized based on the DNA sequence obtained. Ninety-®ve percent of the sequence was determined on both strands and 96% was determined at least twice.
RNA isolation and primer extension analysis
Total RNA was isolated from tissue culture cells or from frozen adult mouse tissues using Trizol Reagent (Life Technologies, Inc.). Selected oligonucleotides from Table 5 (see text) were radiolabeled with T4 polynucleotide kinase and [g-32 P]ATP; hybridizations and primer extensions were performed as previously described . The cDNA products were resolved on 6% denaturing polyacrylamide gels along with a DNA sequencing ladder for precise size determination. The results were visualized by autoradiography after a 16 h exposure at 7808C with intensifying screens.
Reverse transcriptase PCR
Total RNA (10 mg) was reverse transcribed using an oligo(dT) primer, primer t or primer z (refer to text for more details) in a reaction containing 50 mM Tris HCl pH 8.3, 50 mM KCl, 6 mM MgCl 2 , 10 mM dithiothreitol, 80 mg/ ml actinomycin D, and 5 U AMV reverse transcriptase (Life Sciences Inc., St. Petersburg, FL). Reverse transcription (RT) reactions were incubated for 90 min at 458C, and 30 min at 508C. RT products were puri®ed by organic extractions, resuspended in water and used as a template for ampli®cation by polymerase chain reaction (PCR). PCR ampli®cation was performed over 30 cycles of 958C for 45 s, 408C to 508C for 45 s, and 728C for 60 s. PCR products were analysed by electrophoresis on an ethidium bromide stained agarose gel.
Construction of plasmids
The plasmid pRonCAT(72272/+1) was created by a multistep procedure. First, a 2.0 kb XbaI to BamHI fragment from the 5'¯anking region of the mouse Ron gene (nucleotides 72772 to 7801, Figure 2 ) was cloned into pUC19. Secondly, PCR ampli®cation of the region 3' of the BamHI site to the ATG start codon was performed using primers q and r (Table 5 ). This fragment was cloned into the BamHI to KpnI site of pUC19 following the XbaI to BamHI fragment. Finally, the entire insert from pUC19 was excised with HindIII and cloned in both orientations into the multiple cloning site of the promoterless CAT vector pBLCAT6 (Boshart et al., 1992) . These constructs were designated as pRonCAT(72772/+1) and pRonCAT(+1/ 72772) where the 5'¯anking region is in the correct and opposite orientations with respect to the CAT gene. Both plasmids contain 2772 bp of 5'¯anking DNA upstream of the Ron ATG start codon. The plasmid pRonCAT(71843/ +1) was created by digesting pRonCAT(72772/+1) with BglII and ligating the 1843 bp fragment into the BglII site of pBLCAT6. Subsequent Ron/CAT promoter plasmids were created by cloning PCR ampli®cation products containing serial deletions of the Ron promoter region into pBLCAT6 using pRonCat(72772/+1) as the DNA template. pRonCAT(71428/+1) was constructed by PCR ampli®cation with primers a and g (Table 5 ), digestion with XbaI and XhoI, and ligation into the corresponding sites of pBLCAT6. The construct pRonCAT(71015/+1), which contains 1015 bp of 5' Ron¯anking DNA upstream of the translation start site, was obtained by PCR ampli®cation with primers b and g (Table 5 ), restriction digestion with XbaI and XhoI and cloning into the pBLCAT6 vector. pRonCAT(7801/+1) was created by digesting the 1015 bp PCR fragment with BamHI and XhoI and was cloned into the respective sites of pBLCAT6. pRonCAT(7585/+1), pRonCAT(7285/+1), pRonCAT(7185/+1), pRon-CAT(785/+1) and pRonCAT(736/+1) were created by PCR ampli®cation with the forward primers, c, d, e, f and h (Table 5) , respectively, and with the reverse primer g (Table  5 ) followed by XhoI and XbaI digestion and ligation into pBLCAT6. pRonCAT(7465/+1) was obtained by digestion of the 585 bp PCR fragment with PstI and XhoI and ligation into the multiple cloning site of pBLCAT6. pBLCAT5Ron(7375/7285) was created by PCR amplification with primers u and v followed by digestion with HindIII and XbaI. pBLCAT5Ron(7585/7508) was likewise created with primers w and x and digested with HindIII and XbaI. pBLCAT5Ron (7375/7285) and (7585/7508) which contain Ron regulatory regions including nucleotides 7375 to 7285 or nucleotides 7585 to 7508, were cloned into the HindIII ± XbaI multiple cloning sites of pBLCAT5 upstream of the herpes simplex virus (hsv) thymidine kinase (tk) promoter. Plasmids containing PCR products were con®rmed by DNA sequencing and restriction enzyme analyses.
